More on Hansen Medical (HNSN): Q4 beats on a per share basis but comes up short on the revenue side. Catheter sales were up 22% compared to 2011 and up 18% sequentially. Procedures up 15% sequentially and 19% Y/Y, marking the sixth consecutive quarter of procedure growth. For FY13 the company anticipates growth in total robotic system shipments compared to 2012, as well as growth in procedures and catheter sales. Shares -3% AH.